MLchartDataset catalogue

iproplatin

Term · Oncology and biomedicine · MLC-T-ONC-014557

A synthetic second-generation platinum-containing compound related to cisplatin. Iproplatin binds to and forms DNA crosslinks and platinum-DNA adducts, resulting in DNA replication failure and cell death. Although less prone to glutathione inactivation compared to cisplatin, resistance to this agent has been observed in vitro due to repair of platination damage by tumor cells.

Table 1. Record
IdentifierMLC-T-ONC-014557
FieldOncology and biomedicine
AbbreviationCHIP
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-014557",
  "term": "iproplatin",
  "field": "Oncology and biomedicine",
  "definition": "A synthetic second-generation platinum-containing compound related to cisplatin. Iproplatin binds to and forms DNA crosslinks and platinum-DNA adducts, resulting in DNA replication failure and cell death. Although less prone to glutathione inactivation compared to cisplatin, resistance to this agent has been observed in vitro due to repair of platination damage by tumor cells.",
  "abbreviation": "CHIP",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/iproplatin/"
}

Record 9,553 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.